Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
6.03
-0.15 (-2.43%)
Nov 20, 2024, 4:00 PM EST - Market closed
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $203.65 million as of November 21, 2024. Its market cap has increased by 250.00% in one year.
Market Cap
203.65M
Enterprise Value
130.41M
1-Year Change
250.00%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $203.65M, a decrease of -58.28%. That is a compound annual growth rate of -22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 208.71M | 11.38% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 218.42M |
| SOPHiA GENETICS | 217.25M |
| High Tide | 215.35M |
| Zentalis Pharmaceuticals | 213.08M |
| Personalis | 209.21M |
| Inhibrx Biosciences | 206.86M |
| Zura Bio | 205.67M |
| Editas Medicine | 204.72M |